Document is current
Any future updates will be listed below
-
Authors
Hellqvist, Henrik https://orcid.org/0009-0004-4367-7692
Rietz, Hermine
Grote, Ludger
Hedner, Jan
Sommermeyer, Dirk
Kahan, Thomas
Spaak, Jonas
-
Funding
Funding for this research was provided by:
Riksförbundet HjärtLung
Svenska Läkaresällskapet
Karolinska Institutet
Hjärt-Lungfonden (20180584, 20210529)
The Swedish State (20180815, SLL20181049, ALFGBG-966283)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 28 November 2024
Accepted: 5 March 2025
First Online: 14 March 2025
Declaration
:
: LG reports a collaboration with Weinmann GmbH; previous developer of a patent owned by Löwenstein Medical; speaker honoraria for ResMed Inc., Lundbeck, and AstraZeneca; grants from Desitin GmbH, and part ownership of two licensed patents related to sleep apnoea therapy. JH reports a clinical advisory function to Somnomed, and part ownership of two licensed patents related to sleep apnoea therapy. HH is a shareholder in Beat Vascular Health AB and has received consultancy compensation as principal investigator for Neko Health AB. JS has received speaker honoraria from Medtronics, AstraZeneca, Sanofi, Boehringer Ingelheim, and Bayer, and is a shareholder in Beat Vascular Health AB. TK has received research grants to Karolinska Institutet from Medtronic and ReCor Medical, all outside the current study. The other authors report no conflicts.
